ADMA Biologics Stock Plummets on Channel Stuffing Allegations; Law Firm Launches Investigation
Rosen Law Firm investigates ADMA Biologics for allegedly misleading investors. Stock fell 16.6% after short seller Culper Research alleged channel stuffing to inflate revenue.
ADMAsecurities fraudclass action lawsuit